Application 103846

Type
BLA
Sponsor
ELAN PHARM

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103846MyoblocrimabotulinumtoxinB351(a)Rx2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MYOBLOCBotulinum Toxin Type BVIAL5000IU/VIALNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MyoblocRIMABOTULINUMTOXINBSolstice Neurosciences, LLC675cb354-9d13-482e-8ac2-22f709c58b4f2025-10-22Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA103846
ndc (product): 10454-710
ndc (product): 10454-711
ndc (product): 10454-712

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 27 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-710MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-711MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent
10454-712MyoblocrimabotulinumtoxinBSolstice Neurosciences, LLCBLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
66736SUPPL2021-03-11
66733SUPPL2021-03-11
66732SUPPL2021-03-11
59797SUPPL2019-08-21
59796SUPPL2019-08-21
59784SUPPL2019-08-21
9488SUPPL2012-06-15
39729SUPPL2009-08-07
9487SUPPL2009-08-07
23945ORIG2008-08-12
43289ORIG2004-03-17
18671ORIG2004-03-17
9486ORIG2004-03-17